Exploiting senescence for the treatment of cancer
L Wang, L Lankhorst, R Bernards - Nature Reviews Cancer, 2022 - nature.com
Senescence is a cellular response to a variety of stress signals that is characterized by a
stable withdrawal from the cell cycle and major changes in cell morphology and physiology …
stable withdrawal from the cell cycle and major changes in cell morphology and physiology …
Senescence and cancer—role and therapeutic opportunities
Cellular senescence is a state of stable, terminal cell cycle arrest associated with various
macromolecular changes and a hypersecretory, pro-inflammatory phenotype. Entry of cells …
macromolecular changes and a hypersecretory, pro-inflammatory phenotype. Entry of cells …
Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches
Cancer is one of the leading causes of death worldwide. Several treatments are available for
cancer treatment, but many treatment methods are ineffective against multidrug-resistant …
cancer treatment, but many treatment methods are ineffective against multidrug-resistant …
Cellular senescence: aging, cancer, and injury
A Calcinotto, J Kohli, E Zagato… - Physiological …, 2019 - journals.physiology.org
Cellular senescence is a permanent state of cell cycle arrest that occurs in proliferating cells
subjected to different stresses. Senescence is, therefore, a cellular defense mechanism that …
subjected to different stresses. Senescence is, therefore, a cellular defense mechanism that …
Regulation of human telomerase in homeostasis and disease
CM Roake, SE Artandi - Nature Reviews Molecular Cell Biology, 2020 - nature.com
Telomerase is a ribonucleoprotein complex, the catalytic core of which includes the
telomerase reverse transcriptase (TERT) and the non-coding human telomerase RNA (hTR) …
telomerase reverse transcriptase (TERT) and the non-coding human telomerase RNA (hTR) …
Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrence
C Duy, M Li, M Teater, C Meydan, FE Garrett-Bakelman… - Cancer discovery, 2021 - AACR
Patients with acute myeloid leukemia (AML) frequently relapse after chemotherapy, yet the
mechanism by which AML reemerges is not fully understood. Herein, we show that primary …
mechanism by which AML reemerges is not fully understood. Herein, we show that primary …
The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression
J Chen - Cold Spring Harbor perspectives in …, 2016 - perspectivesinmedicine.cshlp.org
P53 is a transcription factor highly inducible by many stress signals such as DNA damage,
oncogene activation, and nutrient deprivation. Cell-cycle arrest and apoptosis are the most …
oncogene activation, and nutrient deprivation. Cell-cycle arrest and apoptosis are the most …
Therapy-induced senescence: an “old” friend becomes the enemy
T Saleh, S Bloukh, VJ Carpenter, E Alwohoush… - Cancers, 2020 - mdpi.com
For the past two decades, cellular senescence has been recognized as a central component
of the tumor cell response to chemotherapy and radiation. Traditionally, this form of …
of the tumor cell response to chemotherapy and radiation. Traditionally, this form of …
Anthracyclines as topoisomerase II poisons: from early studies to new perspectives
J Marinello, M Delcuratolo, G Capranico - International journal of …, 2018 - mdpi.com
Mammalian DNA topoisomerases II are targets of anticancer anthracyclines that act by
stabilizing enzyme-DNA complexes wherein DNA strands are cut and covalently linked to …
stabilizing enzyme-DNA complexes wherein DNA strands are cut and covalently linked to …
Senescent cells in cancer therapy: friends or foes?
Several cancer interventions induce DNA damage and promote senescence in cancer and
nonmalignant cells. Senescent cells secrete a collection of proinflammatory factors …
nonmalignant cells. Senescent cells secrete a collection of proinflammatory factors …